ALK and non-small cell lung carcinoma: Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C <i>de novo</i> mutation: A case report.